Analystreport

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $34.00 price target on the stock.

Syndax Pharmaceuticals, Inc.  (SNDX) 
Last syndax pharmaceuticals, inc. earnings: 3/3 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.syndax.com